Comprehensive evaluation of corticospinal tract metabolites in amyotrophic lateral sclerosis using whole-brain 1H MR spectroscopy

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Govind, Varan ^a   Sharma, Khema R ^a   Maudsley, Andrew A ^a   Arheart, Kristopher L ^a   Saigal, Gaurav ^a   Sheriff, Sulaiman ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CREATININE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CREATINE; DRUG DERIVATIVE; HYDROGEN; N-ACETYLASPARTATE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN ASYMMETRY; BRAIN RADIOGRAPHY; CELL FUNCTION; CEREBRAL PEDUNCLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONA RADIATA (BRAIN); DISEASE SEVERITY; FEMALE; FORCED VITAL CAPACITY; HUMAN; MALE; MOTONEURON; NEUROLOGIC EXAMINATION; POSTERIOR LIMB OF INTERNAL CAPSULE; PRIMARY MOTOR CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; PYRAMIDAL TRACT; SEMIOVAL CENTER; THREE DIMENSIONAL IMAGING; BRAIN; CHEMISTRY; EVALUATION; HOSPITALIZATION; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ASPARTIC ACID; BRAIN; CHOLINE; CREATINE; HUMANS; HYDROGEN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PYRAMIDAL TRACTS; SEVERITY OF ILLNESS INDEX;

EID: 84859945812     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035607     Document Type: Article

References (42)

1. Kato S, (2008) Amyotrophic lateral sclerosis models and human neuropathology: similarities and differences. Acta Neuropathol 115: 97-114.
2. Naganska E, Matyja E, (2011) Amyotrophic lateral sclerosis- looking for pathogenesis and effective therapy. Folia Neuropathol 49: 1-13.
3. Filippi M, Agosta F, Abrahams S, Fazekas F, Grosskreutz J, et al. (2010) EFNS guidelines on the use of neuroimaging in the management of motor neuron diseases. Eur J Neurol 17: 526-e520.
4. Turner MR, Modo M, (2010) Advances in the application of MRI to amyotrophic lateral sclerosis. Expert Opin Med Diagn 4: 483-496.
5. Govindaraju V, Young K, Maudsley AA, (2000) Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 13: 129-153.
6. Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, et al. (2000) MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 21: 647-658.
7. Chan S, Shungu DC, Douglas-Akinwande A, Lange DJ, Rowland LP, (1999) Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. Radiology 212: 763-769.
8. Charil A, Corbo M, Filippi M, Kesavadas C, Agosta F, et al. (2009) Structural and metabolic changes in the brain of patients with upper motor neuron disorders: a multiparametric MRI study. Amyotroph Lateral Scler 10: 269-279.
9. Kalra S, Hanstock CC, Martin WR, Allen PS, Johnston WS, (2006) Detection of cerebral degeneration in amyotrophic lateral sclerosis using high-field magnetic resonance spectroscopy. Arch Neurol 63: 1144-1148.
10. Pohl C, Block W, Karitzky J, Traber F, Schmidt S, et al. (2001) Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 58: 729-735.
11. Rooney WD, Miller RG, Gelinas D, Schuff N, Maudsley AA, et al. (1998) Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS. Neurology 50: 1800-1805.
12. Sarchielli P, Pelliccioli GP, Tarducci R, Chiarini P, Presciutti O, et al. (2001) Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 43: 189-197.
13. Unrath A, Ludolph AC, Kassubek J, (2007) Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol 254: 1099-1106.
14. Block W, Traber F, Flacke S, Jessen F, Pohl C, et al. (2002) In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration. Amino Acids 23: 317-323.
15. Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, et al. (2004) Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 5: 141-149.
16. Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, et al. (2007) Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 68: 1402-1410.
17. Yin H, Lim CC, Ma L, Gao Y, Cai Y, et al. (2004) Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J Neurol 251: 1249-1254.
18. Wang S, Poptani H, Woo JH, Desiderio LM, Elman LB, et al. (2006) Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 239: 831-838.
19. Pyra T, Hui B, Hanstock C, Concha L, Wong JC, et al. (2010) Combined structural and neurochemical evaluation of the corticospinal tract in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11: 157-165.
20. Brooks BR, Miller RG, Swash M, Munsat TL, (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 293-299.
21. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, et al. (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169: 13-21.
22. Kent-Braun JA, Walker CH, Weiner MW, Miller RG, (1998) Functional significance of upper and lower motor neuron impairment in amyotrophic lateral sclerosis. Muscle Nerve 21: 762-768.
23. Sharma KR, Saigal G, Maudsley AA, Govind V, (2011) 1H MRS of basal ganglia and thalamus in amyotrophic lateral sclerosis. NMR Biomed 24: 1270-1276.
24. Govind V, Gold S, Kaliannan K, Saigal G, Falcone S, et al. (2010) Whole-brain proton MR spectroscopic imaging of mild-to-moderate traumatic brain injury and correlation with neuropsychological deficits. J Neurotrauma 27: 483-496.
25. Maudsley AA, Darkazanli A, Alger JR, Hall LO, Schuff N, et al. (2006) Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed 19: 492-503.
26. Collins DL, Zijdenbos AP, Kollokian V, Sled JG, Kabani NJ, et al. (1998) Design and construction of a realistic digital brain phantom. IEEE Trans Med Imaging 17: 463-468.
27. Smith SA, Levante TO, Meier BH, Ernst RR, (1994) Computer simulations in magnetic resonnace. An object oriented programming approach. Journal of Magnetic Resonance Ser A 106: 75-105.
28. Oishi K, Faria A, Jiang H, Li X, Akhter K, et al. (2009) Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage 46: 486-499.
29. Zhang Y, Zhang J, Oishi K, Faria AV, Jiang H, et al. (2010) Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy. Neuroimage 52: 1289-1301.
30. Kaufmann P, Pullman SL, Shungu DC, Chan S, Hays AP, et al. (2004) Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology 62: 1753-1757.
31. Gredal O, Rosenbaum S, Topp S, Karlsborg M, Strange P, et al. (1997) Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy. Neurology 48: 878-881.
32. Schuff N, Rooney WD, Miller R, Gelinas DF, Amend DL, et al. (2001) Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis. Magn Reson Med 45: 513-516.
33. Block W, Karitzky J, Traber F, Pohl C, Keller E, et al. (1998) Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 55: 931-936.
34. Maudsley AA, Domenig C, Sheriff S, (2010) Reproducibility of serial whole-brain MR spectroscopic imaging. NMR Biomed 23: 251-256.
35. Simmons ML, Frondoza CG, Coyle JT, (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45: 37-45.
36. Ellis CM, Simmons A, Andrews C, Dawson JM, Williams SC, et al. (1998) A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings. Neurology 51: 1104-1109.
37. Penfield W, Boldrey E, (1937) Somatic motor and sensory representation in the cerebral cortex of man as studied by electrical stimulation. Brain 60: 389-443.
38. Abe K, Takanashi M, Watanabe Y, Tanaka H, Fujita N, et al. (2001) Decrease in N-acetylaspartate/creatine ratio in the motor area and the frontal lobe in amyotrophic lateral sclerosis. Neuroradiology 43: 537-541.
39. Sivak S, Bittsansky M, Kurca E, Turcanova-Koprusakova M, Grofik M, et al. (2010) Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology 52: 1079-1085.
40. Kalra S, Tai P, Genge A, Arnold DL, (2006) Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopic imaging. J Neurol 253: 1060-1063.
41. Kalra S, Cashman NR, Genge A, Arnold DL, (1998) Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy. Neuroreport 9: 1757-1761.
42. Bradley WG, Bowen BC, Pattany PM, Rotta F, (1999) 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 169: 84-86.